Updated on 8 February 2026
3D-Bioprinted Scaffolds for Drug Delivery & Tissue Regeneration Partnership
Research and Development Scientist at BlooCell
Istanbul, Türkiye
About
ABOUT BLOOCELL
BlooCell Health Technologies (Turkey) develops 3D-bioprinted tissue scaffolds using bioprinting technology. We have clinically approved products (BCRM) for bone and dental regeneration and are expanding into cardiovascular, corneal, cartilage, pancreatic, and dermal applications.
PARTNERSHIP OPPORTUNITY
We are seeking partners to co-develop multifunctional scaffold platforms combining:
• Controlled drug delivery systems (growth factors, chemotherapeutics, antibiotics)
• Tissue-specific regeneration (cardiovascular, pancreas, cornea, cartilage, dermal)
• Surface functionalization strategies (polydopamine, bioactive coatings)
OUR CAPABILITIES
✓ Clinically validated 3D Bioprinted scaffold manufacturing
✓ Precise fiber architecture control
✓ Tunable mechanical properties matching native tissues
✓ Scalable production under GMP-compliant processes
✓ Experience in regulatory pathways (CE marking)
LOOKING FOR PARTNERS WITH EXPERTISE IN:
• Drug formulation & encapsulation technologies
• Controlled release systems & pharmacokinetics
• Bioactive molecule integration (proteins, peptides, small molecules)
• In vivo drug-device combination studies
• Clinical translation & regulatory affairs for combination products
• Cancer treatment platforms (especially pancreatic cancer)
TARGET HORIZON EUROPE CALLS
• HORIZON-HLTH-2026-01-TOOL-03 (NAMs)
• HORIZON-HLTH-2026-01-IND-03 (Regulatory science)
• HORIZON-MISS-2025-CANCER topics
• UNCAN-Connect platform collaboration
COLLABORATION MODELS
We are open to:
→ WP partner in consortium (biomaterial manufacturing & characterization)
→ Co-development agreements
→ Joint IP development
→ Technology validation partner
→ SME-academia-clinic triangulation
📧 CONTACT: sema.bayraktar@bloocell.com
#MEW #3DBioprinting #DrugDelivery #TissueEngineering #Scaffolds #Biomaterials
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Oscar Castano
Full Professor at Universitat de Barcelona
Barcelona, Spain
Project cooperation
Seeking Consortia & Expertise Offer for Tool-02 & Tool-03 (Bioprinting Projects)
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Hazal Evecen
Business Development Specialist at Galata Innovation
İstanbul, Türkiye
Project cooperation
Human Collagen and Xeno-free Human ECM for Medical Applications
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
Fabian Trumper
CEO at Arrakis Bio
Modi'in, Israel